Ovid Therapeutics (OVID) Q2 2025 Earnings

May 13Confirmed
Q3 2024
Q4 2024
Q1 2025
Q2 2025
-0.22
-0.11
0.01
0.12

Details

Expected EPS
-0.137517
Actual EPS
-0.14
Surprise EPS
-0
Surprise Percent
-1.81%

Description

⁨Ovid Therapeutics⁩ (⁦OVID⁩) has reported earnings of ⁦-0.14⁩ per share for ⁦Q2 2025⁩.

0 Comments

Share your thoughts